Active ingredients
Pharmacological Group
Used in the treatment of
- T14.1 Open wound of unspecified body region
- R53 Malaise and fatigue
- L98.4 Chronic ulcer of skin, not elsewhere classified
- L71 Rosacea
- L56 Other acute skin changes due to ultraviolet radiation
- L30.9 Dermatitis, unspecified
- L21 Seborrhoeic dermatitis
- L20 Atopic dermatitis
- K90 Intestinal malabsorption
- K74 Fibrosis and cirrhosis of liver
- K73 Chronic hepatitis, not elsewhere classified
- K14.0 Glossitis
- K13.7 Other and unspecified lesions of oral mucosa
- K13.0 Diseases of lips
- K12 Stomatitis and related lesions
- H53.1 Subjective visual disturbances
- H26 Other cataract
- H25 Senile cataract
- H20 Iridocyclitis
- H17 Corneal scars and opacities
- H16 Keratitis
- H10.9 Conjunctivitis, unspecified
- E53.0 Riboflavin deficiency
- E46 Unspecified protein-energy malnutrition
- B37 Candidiasis
- B15 Acute hepatitis A
- T66 Unspecified effects of radiation
- L87 Transepidermal elimination disorders
- L29.9 Pruritus, unspecified
- L20-L30 Dermatitis and eczema
- B15-B19 Viral hepatitis
- L56.9 Acute skin change due to ultraviolet radiation, unspecified